beta-hydroxypentanoate
Small moleculeexperimental
3-Hydroxyvaleric acid is the organic compound with the formula CH3CH2CH(OH)CH2CO2H. It is one of the hydroxypentanoic acids. It is made from odd carbon fatty acids in the liver and rapidly enters the brain. As opposed to 4-carbon ketone bodies, 3-hydroxyvaleric acid is anaplerotic, meaning it can refill the pool of TCA cycle intermediates. The triglyceride triheptanoin is used clinically to produce 3-hydroxyvalerate. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00328159)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- Wikipedia3-Hydroxyvaleric acid ↗
- Wikipedia3-Hydroxypentanoic acid ↗
Also known as
- beta-hydroxypentanoate
- beta-hydroxypentanoate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00328159 | N/A | Jun 1, 2006 | University of Paris |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Paris | Academic/Hospital | 1 | 1 | 1 | 2006 |
1 organizations
Page 1 / 1